Please complete this follow-up survey to help us measure the impact of our program on your practice. Please share an example of how this program influenced your practice and/or research Do you believe your participation in this activity has DefinitelyVery likelyPossiblyUnlikelyNot at allNA Led to practice improvements Led to practice improvements - Definitely Led to practice improvements - Very likely Led to practice improvements - Possibly Led to practice improvements - Unlikely Led to practice improvements - Not at all Led to practice improvements - NA Led to patient benefits Led to patient benefits - Definitely Led to patient benefits - Very likely Led to patient benefits - Possibly Led to patient benefits - Unlikely Led to patient benefits - Not at all Led to patient benefits - NA What change(s) or improvement(s) have you made to your clinical practice following your participation in this activity? Select all that apply. * Update my knowledge of emerging therapies Improve selection and adjustment agents Increase screening for high-risk patients Improve setting targets for MKI therapy Improve optimization of therapy to avoid adverse events This activity confirms my practice Not in practice Other... What change(s) or improvement(s) have you made to your clinical practice following your participation in this activity? Select all that apply. Other... In which area(s) do you feel your patients have benefited as a result of your participation in this activity? Select all that apply. * Improved optimization of therapy to meet targets Increased screening Minimized adverse effects Reduced risk of contra-indications No patient benefit Not in practice Other... In which area(s) do you feel your patients have benefited as a result of your participation in this activity? Select all that apply. Other... Which of the following barriers have prevented you from optimally diagnosing and treating patients with thyroid cancer? Select all that apply. * Cost of therapy Difficulty assessing benefits and risks of therapies Difficulty setting appropriate lipid targets Adverse events with current therapies Lack of indicated use for new therapies Patient adherence No barriers Other... Which of the following barriers have prevented you from optimally diagnosing and treating patients with thyroid cancer? Select all that apply. Other... Please share any additional feedback you have about the program. Insert your name and email address if you want to be entered into the drawing for a free copy of ESAP 2015 Leave this field blank
